Analyst Recommendations
39.27 -0.35(-0.87%)10/04/2024
Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharmaceuticals Inc (MIRM)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 14 |
Overweight | 7 |
Outperform | 5 |
Market Outperform | 4 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades